The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats
Abstract
Background: Cell-free DNA circulating in blood is a candidate biomarker for malignant tumors. Unlike uniformly truncated DNA released from apoptotic nondiseased cells, DNA released from dead cancer cells varies in size. We developed a novel method to measure the ratio of longer to shorter DNA fragments (DNA integrity) in serum as a potential biomarker for patients with colorectal cancer (CRC) or periampullary cancers (PACs). Methods: Sera from 32 patients with CRC (3 stage I, 14 stage II, 6 stage III, and 9 stage IV patients), 19 patients with PACs (2 stage I, 9 stage II, 1 stage III, and 7 stage IV patients), and 51 healthy volunteers were assessed by quantitative real-time PCR of ALU repeats (ALU-qPCR) with 2 sets of primers (115 and 247 bp) amplifying different lengths of DNA. We used serum directly as a template for ALU-qPCR without DNA purification. DNA integrity was determined as ratio of qPCR results of 247-bp ALU over 115-bp ALU. Results: ALU-qPCR had a detection limit of 0.01 pg of DNA. Eliminating DNA purification reduced technical artifacts and reagent/labor costs. Serum DNA integrity was significantly increased for stage I/II and III/IV CRC and stage I/II and III/IV PACs (P = 0.002, P = 0.006, P = 0.022, and P <0.0001, respectively). ROC curves for detecting CRC and PACs had areas under the curves of 0.78 and 0.80, respectively. Conclusions: Direct ALU-qPCR is a robust, highly sensitive, and high-throughput method to measure serum DNA integrity. DNA integrity is a potential serum biomarker for detection and evaluation of CRC and PACs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143
(1977) · PubMed · Cited by 1,801
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
The origin of interspersed repeats in the human genome
Smit, A. F. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80030-x · Cited by 611
Size Distributions of Maternal and Fetal DNA in Maternal Plasma
Chan, K. C. A., Zhang, J., Hui, A. B. Y., Wong, N., Lau, T. K., Leung, T. N., Lo, K.-W., Huang, D. W. S., & Lo, Y. M. D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024893 · Cited by 584
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
Anker, P., Mulcahy, H., Qi Chen, X., & Stroun, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006260319913 · Cited by 451
Patterns of failure after curative resection of pancreatic carcinoma
Griffin, J. F., Smalley, S. R., Jewell, W., Paradelo, J. C., Reymond, R. D., Hassanein, R. E. S., & Evans, R. G. (1990) · Cancer · doi:10.1002/1097-0142(19900701)66:1<56::aid-cncr2820660112>3.0.co;2-6 · Cited by 434
Giacona, M. B., Ruben, G. C., Iczkowski, K. A., Roos, T. B., Porter, D. M., & Sorenson, G. D. (1998) · Pancreas · doi:10.1097/00006676-199807000-00012 · Cited by 387
Increasing incidence of primary brain lymphoma in the US
Eby, N. L., Grufferman, S., Flannelly, C. M., Schold, S. C., Vogel, F. S., & Burger, P. C. (1988) · Cancer · doi:10.1002/1097-0142(19881201)62:11 · Cited by 386
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Repeats in genomic DNA: mining and meaning
Jurka, J. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80067-5 · Cited by 303
Time Course of Early and Late Changes in Plasma DNA in Trauma Patients
Lam, N. Y. L., Rainer, T. H., Chan, L. Y. S., Joynt, G. M., & Lo, Y. M. D. (2003) · Clinical Chemistry · doi:10.1373/49.8.1286 · Cited by 182
Insertion and/or deletion of many repeated DNA sequences in human and higher ape evolution.
Hwu, H. R., Roberts, J. W., Davidson, E. H., & Britten, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3875 · Cited by 180
Graham, R. A., Wang, S., Catalano, P. J., & Haller, D. G. (1998) · Annals of Surgery · doi:10.1097/00000658-199807000-00009 · Cited by 176
Recurrence of exocrine pancreatic cancer--local or hepatic?
Westerdahl, J., Andrén‐Sandberg, Å., & Ihse, I. (1993) · PubMed · Cited by 175
Holdenrieder, S., Stieber, P., von Pawel, J., Raith, H., Nagel, D., Feldmann, K., & Seidel, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0625 · Cited by 140
Cell-Free DNA in Serum and Plasma: Comparison of ELISA and Quantitative PCR
Holdenrieder, S., Stieber, P., Chan, L. Y. S., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.049320 · Cited by 125
Umetani, N., Hiramatsu, S. H., & Hoon, D. S. �. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.040 · Cited by 113
Self-citationQuantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic Malignancies
Herrera, L. J., Raja, S., Gooding, W. E., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039263 · Cited by 107
Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients
Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91
Self-citationSorenson, G. D. (2000) · PubMed · Cited by 84
Gu, Z., Wang, H., Nekrutenko, A., & Li, W. (2000) · Gene · doi:10.1016/s0378-1119(00)00434-0 · Cited by 82
Detection of K- ras mutations in the plasma DNA of pancreatic cancer patients
Nakao, A., Hibi, K., Kaneko, T., Takeda, S., Inoue, S., Okochi, O., Uemura, T., & Nagasaka, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1245-1 · Cited by 70
Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical Utility
Taback, B., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.002 · Cited by 64
Self-citationAllelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
Fujimoto, A., O'Day, S. J., Taback, B., Elashoff, D. A., & Hoon, D. S. �. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0957 · Cited by 51
Self-citationPersistence of K-ras mutations in plasma after colorectal tumor resection.
Lindforss, U., Zetterquist, H., Papadogiannakis, N., et al. (2005) · PubMed · Cited by 48
Cited by
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Self-citationColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Heitzer, E., Ulz, P., & Geigl, J. B. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.222679 · Cited by 767
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
The emerging role of cell-free DNA as a molecular marker for cancer management
Bronkhorst, A. J., Ungerer, V., & Holdenrieder, S. (2019) · Biomolecular Detection and Quantification · doi:10.1016/j.bdq.2019.100087 · Cited by 566
Metadata
- Authors
- Umetani, N., Kim, J., Hiramatsu, S., Reber, H. A., Hines, O. J., Bilchik, A. J., & Hoon, D. S. B.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-01
- Volume
- 52
- Issue
- 6
- Pages
- 1062-1069
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1990915258
- Cited by
- 331
- References
- 30
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.